Infectious Diseases

After a clinical trial showed positive results in 89% of participants, a new drug regimen was approved by the FDA for highly drug-resistant forms of pulmonary tuberculosis.

A new 3-drug antibacterial drug injection containing an FDA-approved antibiotic and a new β-lactamase inhibitor has been approved.

After a multinational, double-blind trial showed positive results, the FDA approved a new indication for an already-approved antibacterial drug.

The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...

After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.

The antibacterial drug is approved to treat travelers’ diarrhea, which is defined as having 3 or more unformed stools in 24 hours, in a person who is traveling.

The US Food and Drug Administration has approved baloxavir marboxil (Xofluza)

In an FDA statement, Scott Gotlieb, MD, discusses the pathogen added to the list of foodborne pathogens to routinely test for, why it was added, and the FDA’s ongoing efforts to screen domestic and imported...

The FDA has approved an 8-aminoquinoline derivative for the treatment of patients with Plasmodium vivax malaria.

With concerns of bioterrorism in mind, the US Food and Drug Administration has approved the first drug with an indication for the treatment of smallpox.